Wuhan Healthgen Biotechnology Corp. (SHA:688765)
China flag China · Delayed Price · Currency is CNY
78.58
+0.62 (0.80%)
At close: Dec 5, 2025

SHA:688765 Statistics

Total Valuation

SHA:688765 has a market cap or net worth of CNY 28.09 billion. The enterprise value is 28.47 billion.

Market Cap 28.09B
Enterprise Value 28.47B

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

SHA:688765 has 357.50 million shares outstanding. The number of shares has increased by 1.41% in one year.

Current Share Class 357.50M
Shares Outstanding 357.50M
Shares Change (YoY) +1.41%
Shares Change (QoQ) +6.92%
Owned by Insiders (%) 36.25%
Owned by Institutions (%) 18.29%
Float 154.85M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 989.41
PB Ratio 52.91
P/TBV Ratio 63.10
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -184.36
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -69.72

Financial Position

The company has a current ratio of 0.96, with a Debt / Equity ratio of 0.95.

Current Ratio 0.96
Quick Ratio 0.51
Debt / Equity 0.95
Debt / EBITDA n/a
Debt / FCF -1.24
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -13.35%
Revenue Per Employee 179,703
Profits Per Employee -977,240
Employee Count 158
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) 42.99
Average Volume (20 Days) 5,480,244

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SHA:688765 had revenue of CNY 28.39 million and -154.40 million in losses. Loss per share was -0.57.

Revenue 28.39M
Gross Profit 18.21M
Operating Income -139.47M
Pretax Income -154.40M
Net Income -154.40M
EBITDA n/a
EBIT -139.47M
Loss Per Share -0.57
Full Income Statement

Balance Sheet

The company has 132.37 million in cash and 505.27 million in debt, giving a net cash position of -372.90 million or -1.04 per share.

Cash & Cash Equivalents 132.37M
Total Debt 505.27M
Net Cash -372.90M
Net Cash Per Share -1.04
Equity (Book Value) 530.91M
Book Value Per Share 1.95
Working Capital -11.22M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -73.09 million and capital expenditures -335.20 million, giving a free cash flow of -408.29 million.

Operating Cash Flow -73.09M
Capital Expenditures -335.20M
Free Cash Flow -408.29M
FCF Per Share -1.14
Full Cash Flow Statement

Margins

Gross Margin 64.12%
Operating Margin -491.20%
Pretax Margin -543.81%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

SHA:688765 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.41%
Shareholder Yield -1.41%
Earnings Yield -0.55%
FCF Yield -1.45%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2